Toll Access
Introduction to Immunohematology Special Edition on Drug-Induced Immune Cytopenias
Patricia A. Arndt/ Regina M. Leger
DOI: 10.21307/immunohematology-2019-097
Publications
Immunohematology
Journal of Blood Group Serology and Molecular Genetics
American National Red Cross
Subject: Medical Laboratory Technology
ISSN: 0894-203X
eISSN: 1930-3955
FEATURED ARTICLES
The Cromer blood group system: an update
SEARCH WITHIN CONTENT
Archive
Volume 37
(2021)
Volume 36
(2020)
Volume 35
(2019)
Volume 34
(2018)
Volume 33
(2017)
Volume 32
(2016)
Volume 31
(2015)
Volume 30
(2014)
Volume 29
(2013)
Volume 28
(2012)
Volume 27
(2011)
Volume 26
(2010)
Volume 25
(2009)
Volume 24
(2008)
Volume 23
(2007)
Volume 22
(2006)
Volume 21
(2005)
Volume 20
(2004)
Volume 19
(2003)
Volume 18
(2002)
Volume 17
(2001)
Volume 16
(2000)
Volume 15
(1999)
Volume 14
(1998)
Volume 13
(1997)
Volume 12
(1996)
Volume 11
(1995)
Volume 10
(1994)
Volume 9
(1993)
Volume 8
(1992)
Volume 7
(1991)
Volume 6
(1990)
Volume 5
(1989)
Volume 4
(1988)
Volume 3
(1987)
Trending Articles
- Recognizing and resolving ABO discrepancies
- Separation of multiple antibodies by adsorption with allogeneic red blood cells
- Identifying obstetrics patients in whom RHD genotyping can be used to assess risk of D alloimmunization
- Neonatal testing leading to the identification of Bh (para-Bombay) phenotype in the mother: case report with review of the literature
VOLUME 30 , ISSUE 2 (June 2014) - List of articles
Toll Access
Drug-induced immune hemolytic anemia: the last 30 years of changes
Patricia A. Arndt
DOI: 10.21307/immunohematology-2019-098
Toll Access
Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms
Brian R. Curtis
DOI: 10.21307/immunohematology-2019-099
Toll Access
Drugs that have been shown to cause druginduced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007
George Garratty/ Patricia A. Arndt
DOI: 10.21307/immunohematology-2019-100
Toll Access
Diagnostic pitfalls of drug-induced immune hemolytic anemia
Abdulgabar Salama/ Beate Mayer
DOI: 10.21307/immunohematology-2019-101
Toll Access
How we investigate drug-induced immune hemolytic anemia
Regina M. Leger/ Patricia A. Arndt/ George Garratty
DOI: 10.21307/immunohematology-2019-102
Toll Access
Drug-induced immune neutropenia/ agranulocytosis
Brian R. Curtis
DOI: 10.21307/immunohematology-2019-103
No Record Found..